Accretion Nutraveda IPO Live Subscription Status

Real-time subscription data from BSE & NSE with category-wise breakdowns

📈 GMP Today 🎟️ Allotment Status 📄 Full IPO Details Listed at BSE · Registrar: Kfin Technologies Ltd.
Listed SME
Price: ₹122 - ₹129 Lot: 1000 Min: ₹1,29,000 Period: 28 Jan - 30 Jan
Subscribed
1.91x
Total Demand
₹31 Cr
Applications
811
Subscription (Shares)
CategoryOfferedAppliedTimes
QIB 3,62,000 3,67,000 1.01
NII 2,76,000 6,69,000 2.42
bNII (>10 Lakh) 1,84,000 4,55,000 2.47
sNII (2-10 Lakh) 92,000 2,14,000 2.33
Retail 6,40,000 14,04,000 2.19
TOTAL 12,78,000 24,40,000 1.91
Application Breakup
CategoryReservedApplicationsTimes
NII 138 334 2.42
bNII (>10 Lakh) 92 57 0.62
sNII (2-10 Lakh) 46 107 2.33
Retail 640 1,404 2.19
TOTAL 916 811 0.89
Subscription (Crores)
CategoryOfferedDemandTimes
QIB 4.67 4.73 1.01
NII 3.56 8.63 2.42
bNII (>10 Lakh) 2.37 5.87 2.47
sNII (2-10 Lakh) 1.19 2.76 2.33
Retail 8.26 18.11 2.19
TOTAL 16.49 31.48 1.91
Subscription by Category 1× = fully subscribed · capped 10×
QIB
1.01x
NII
2.42x
bNII (>10 Lakh)
2.47x
sNII (2-10 Lakh)
2.33x
Retail
2.19x
Estimated Allotment Chance
Retail 52.1% (2.19x subscribed)
High chance
S-HNI (2-10L) 42.9% (2.33x subscribed)
Moderate chance
B-HNI (>10L) 100.0% (2.47x subscribed)
High chance
If 100 retail investors apply, approximately 52 will get allotment.
Estimated from current subscription data, calibrated against published basis-of-allotment results. Actual allotment depends on the number of applications received and SEBI's allotment rules — draw of lots for Retail, Employee and NII; proportionate for QIB.
Disclaimer: Subscription data is sourced from BSE and NSE. Please verify with official exchange websites before making any investment decisions. This information is for educational purposes only and should not be construed as investment advice.

Accretion Nutraveda IPO Subscription — Detailed Analysis

Where Accretion Nutraveda Subscription Stands Today

Accretion Nutraveda IPO has been subscribed 1.91 times overall — fully covered, indicating decent investor interest. Watch how this evolves through the remaining bidding window. A total of 811 applications have been received so far.

Accretion Nutraveda IPO Subscription — FAQs

Accretion Nutraveda IPO is currently subscribed 1.91 times overall.

Accretion Nutraveda IPO is open for subscription from January 28, 2026 to January 30, 2026.

The price band for Accretion Nutraveda IPO is ₹122 - ₹129 per share.

New to subscription data? The hub explains what QIB, NII and Retail mean and how to read the table. For allotment odds from these numbers, see the allotment chances calculator or our IPO allotment process explainer.

GMP Update